Chandra M Sehgal Selected Research

Chandra M Sehgal Research Topics

27	Neoplasms (Cancer) 03/2023 - 02/2002
7	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 01/2019
6	Melanoma (Melanoma, Malignant) 06/2019 - 12/2007
3	Fibrosis (Cirrhosis) 03/2023 - 01/2019
3	Hypoxia (Hypoxemia) 01/2020 - 08/2009
2	Tendon Injuries 05/2022 - 01/2019
2	Ischemia 01/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 10/2007 - 04/2003
2	Carcinoma (Carcinomatosis) 04/2003 - 02/2002
1	Myocardial Infarction 12/2023
1	Ischemic Stroke 12/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2023
1	Pulmonary Embolism 12/2023
1	Liver Diseases (Liver Disease) 03/2023
1	Squamous Cell Carcinoma of Head and Neck 11/2022
1	Necrosis 01/2021
1	Portal Hypertension 01/2021
1	Hyperthermia 01/2021
1	Hemorrhage 01/2021
1	Inflammation (Inflammations) 09/2020
1	Sclerosis 01/2020
1	Bronchiolitis Obliterans Syndrome 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Contracture 01/2020
1	Neoplasm Metastasis (Metastasis) 06/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fibrosarcoma 05/2005

9	Contrast MediaIBA 01/2021 - 04/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 12/2005
4	perflutren (octafluoropropane)FDA Link 05/2010 - 12/2007
3	Hydralazine (Apresoline)FDA LinkGeneric 03/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 09/2020 - 05/2005
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2020 - 01/2019
2	N-hydroxysuccinimide S-acetylthioacetate (SATA)IBA 05/2010 - 12/2007
2	FS 069 (Optison)FDA Link 12/2007 - 03/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2007 - 04/2003
1	cupric sulfide (CuS)IBA 03/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Oxygen (Dioxygen)IBA 09/2020
1	Noble Gases (Rare Gases)IBA 01/2020
1	XenonIBA 01/2020
1	Melanins (Melanin)IBA 06/2019
1	HydrogelsIBA 01/2019
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2019
1	PlacebosIBA 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2009
1	ErbB Receptors (EGF Receptor)IBA 08/2009
1	phosphono-platelet activating factorIBA 09/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008
1	Indicators and Reagents (Reagents)IBA 10/2007
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 05/2005
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2005
1	chemotactic factor inactivatorIBA 07/2003
1	Interleukin-12 (IL 12)IBA 02/2002
1	Antineoplastic Agents (Antineoplastics)IBA 02/2002

15	Therapeutics 12/2022 - 02/2002
8	Microbubbles 12/2023 - 12/2007
7	Ultrasonic Therapy 01/2021 - 06/2009
4	Radiotherapy 09/2020 - 04/2003
3	Intravenous Administration 10/2022 - 02/2015
2	Precision Medicine 12/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 04/2015 - 08/2009
2	Aftercare (After-Treatment) 02/2015 - 09/2008
2	Intravenous Injections 05/2010 - 09/2008
1	Induction Chemotherapy 11/2022
1	Lasers (Laser) 01/2020
1	Palliative Care (Palliative Therapy) 01/2019
1	Injections 01/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 02/2014
1	Photochemotherapy (Photodynamic Therapy) 05/2005